Artax Biopharma's Series B - II Round

Artax Biopharma raised a round of funding on August 12, 2019.

Artax Biopharma is a clinical stage biopharmaceutical company developing therapies for autoimmune diseases. Its pipeline of drugs is based on science that targets the interaction between T-cell recept…

Articles about Artax Biopharma's Series B - II Round: